|
US3541130A
(en)
|
1967-02-06 |
1970-11-17 |
Boehringer Sohn Ingelheim |
1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
|
|
US4613676A
(en)
*
|
1983-11-23 |
1986-09-23 |
Ciba-Geigy Corporation |
Substituted 5-amino-4-hydroxyvaleryl derivatives
|
|
US4743607A
(en)
|
1987-05-29 |
1988-05-10 |
Merrell Dow Pharmaceuticals Inc. |
Cardiotonic tricyclic imidazolones
|
|
JPH04503205A
(ja)
|
1988-05-02 |
1992-06-11 |
ナフッチィ，エヌ，エリック |
神経学的活性化合物
|
|
US5028622A
(en)
|
1988-05-06 |
1991-07-02 |
Ajinomoto Company, Inc. |
Administration of amino acids as treatment for neurodegenerative disorders
|
|
US5321029A
(en)
|
1988-11-14 |
1994-06-14 |
Beecham-Wuelfing Gmbh & Co.K.G. |
Xanthines
|
|
CA2010531A1
(en)
*
|
1989-03-06 |
1990-09-06 |
Werner Neidhart |
Amino acid derivatives
|
|
EP0536671B1
(de)
|
1991-10-07 |
1996-03-06 |
Hoechst Aktiengesellschaft |
Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung
|
|
US5608067A
(en)
|
1993-12-09 |
1997-03-04 |
Afonso; Adriano |
4-substituted pyrazoloquinoline derivatives
|
|
GB9402331D0
(en)
|
1994-02-07 |
1994-03-30 |
Univ Mcgill |
Nerve growth factor structural analogs and their uses
|
|
JPH08119922A
(ja)
|
1994-10-21 |
1996-05-14 |
Torii Yakuhin Kk |
ｏ−ピバロイル−チロシン誘導体
|
|
AU4117396A
(en)
*
|
1994-11-29 |
1996-06-19 |
Novartis Ag |
Morpholinoethylamide derivatives
|
|
JPH1081661A
(ja)
|
1995-10-23 |
1998-03-31 |
Sankyo Co Ltd |
ヒドロキサム酸誘導体
|
|
US5958875A
(en)
|
1996-03-29 |
1999-09-28 |
The Regents Of The University Of California |
Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
|
|
WO1997037228A1
(en)
|
1996-03-29 |
1997-10-09 |
The Trustees Of Boston University |
Methods for diagnosing and treating alzheimer's disease
|
|
WO1997042168A1
(en)
|
1996-05-06 |
1997-11-13 |
Zeneca Limited |
Thio derivatives of hydroxamic acids
|
|
GB9613547D0
(en)
|
1996-06-27 |
1996-08-28 |
Pharmacia Spa |
Matrix metalloproteinase inhibitors
|
|
GB9616105D0
(en)
|
1996-07-31 |
1996-09-11 |
Univ Kingston |
TrkA binding site of NGF
|
|
GB9715962D0
(en)
|
1996-08-23 |
1997-10-01 |
Zeneca Ltd |
Sulfonamides
|
|
GB2338957B
(en)
|
1997-02-19 |
2001-08-01 |
Berlex Lab |
N-heterocyclic derivatives as nos inhibitors
|
|
FR2762315B1
(fr)
|
1997-04-22 |
1999-05-28 |
Logeais Labor Jacques |
Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf alpha
|
|
WO1998054123A1
(en)
|
1997-05-30 |
1998-12-03 |
Warner-Lambert Company |
Substituted peptidylamine calcium channel blockers
|
|
US6342507B1
(en)
|
1997-09-05 |
2002-01-29 |
Isotechnika, Inc. |
Deuterated rapamycin compounds, method and uses thereof
|
|
US20020022657A1
(en)
*
|
1998-02-11 |
2002-02-21 |
Francine Gervais |
Methods for modulating neuronal cell death
|
|
AU2960599A
(en)
|
1998-03-30 |
1999-10-18 |
Akira Karasawa |
Quinazoline derivatives
|
|
FR2783519B1
(fr)
|
1998-09-23 |
2003-01-24 |
Sod Conseils Rech Applic |
Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
|
|
CN1346272A
(zh)
|
1998-11-06 |
2002-04-24 |
罗赫诊断器材股份有限公司 |
用作与基质金属蛋白酶相关疾病治疗剂的胱氨酸衍生物
|
|
CA2355137A1
(en)
|
1998-12-18 |
2000-06-29 |
Martyn Clive Pritchard |
Non-peptide nk1 receptors antagonists
|
|
US6583148B1
(en)
|
1999-04-08 |
2003-06-24 |
Krenitsky Pharmaceuticals, Inc. |
Neurotrophic substituted pyrimidines
|
|
US6492380B1
(en)
|
1999-05-17 |
2002-12-10 |
Queen's University At Kingston |
Method of inhibiting neurotrophin-receptor binding
|
|
TWI275587B
(en)
|
1999-06-17 |
2007-03-11 |
Takeda Chemical Industries Ltd |
A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
|
|
US6858577B1
(en)
|
1999-06-29 |
2005-02-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Indole peptidomimetics as thrombin receptor antagonists
|
|
DE19939910A1
(de)
|
1999-08-23 |
2001-03-01 |
Morphochem Ag |
Neue Verbindungen, die Tryptase-Aktivität hemmen
|
|
JP2003508512A
(ja)
|
1999-09-08 |
2003-03-04 |
ギルフォード ファーマシュウティカルズ インコーポレイテッド |
非ペプチド性サイクロフィリン結合化合物とその用途
|
|
ES2276706T3
(es)
|
1999-12-08 |
2007-07-01 |
Teijin Limited |
Antagonistas del receptor ccr5 de aminas ciclicas.
|
|
ATE340571T1
(de)
|
2000-01-18 |
2006-10-15 |
Univ Mcgill |
Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen
|
|
AR028606A1
(es)
|
2000-05-24 |
2003-05-14 |
Smithkline Beecham Corp |
Nuevos inhibidores de mmp-2/mmp-9
|
|
US6699989B1
(en)
|
2000-08-28 |
2004-03-02 |
B. Vithal Shetty |
Antiviral and antimicrobial guanidine or biguanidine derivatives
|
|
WO2002048660A1
(en)
|
2000-12-13 |
2002-06-20 |
Spelman College |
Multiplex coherent raman spectroscopy detector and method
|
|
CN101068772A
(zh)
|
2001-07-11 |
2007-11-07 |
艾伦药物公司 |
N－(3－氨基－2－羟基－丙基)取代烷基酰胺化合物
|
|
US20040248984A1
(en)
|
2001-08-29 |
2004-12-09 |
Josef Krieglstein |
Use of $g(b)-adrenoceptor agonists for the treatment of neurodegenerative diseases
|
|
WO2003030836A2
(en)
|
2001-10-12 |
2003-04-17 |
Case Western Reserve University |
Neuronal regeneration
|
|
AU2002359376B2
(en)
|
2001-11-08 |
2008-01-10 |
Elan Pharmaceuticals, Inc. |
N, N'-substituted-1,3-diamino-2-hydroxypropane derivatives
|
|
AU2003223093B2
(en)
|
2002-05-03 |
2010-02-04 |
Israel Institute For Biological Research |
Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
|
|
UA77526C2
(en)
|
2002-06-07 |
2006-12-15 |
Sanofi Aventis |
Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
|
|
EP1553964A4
(en)
|
2002-09-25 |
2009-08-12 |
Georgia Tech Res Inst |
KETOAMID INHIBITORS IN CHRONIC NERVE DISEASES
|
|
WO2004031145A2
(en)
|
2002-10-02 |
2004-04-15 |
Bristol-Myers Squibb Company |
Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
|
|
US20040186044A1
(en)
|
2002-11-06 |
2004-09-23 |
Cosgaya Jose Miguel |
Modulation of myelination by interaction with P75 and TRK receptors
|
|
US20050154011A1
(en)
|
2003-02-20 |
2005-07-14 |
The Procter & Gamble Company |
Tetrahydroisoquinolnyl sulfamic acids
|
|
GB0304433D0
(en)
|
2003-02-27 |
2003-04-02 |
Xceleron Ltd |
Improvements relating to chemical libraries
|
|
WO2005044810A1
(en)
|
2003-10-30 |
2005-05-19 |
Janssen Pharmaceutica, N.V. |
Glyt2 modulators
|
|
US7671072B2
(en)
|
2003-11-26 |
2010-03-02 |
Pfizer Inc. |
Aminopyrazole derivatives as GSK-3 inhibitors
|
|
WO2005070407A1
(en)
|
2004-01-21 |
2005-08-04 |
Elan Pharmaceuticals, Inc. |
Methods of treatment of amyloidosis using aspartyl-protease inihibitors
|
|
JP4775259B2
(ja)
|
2004-03-31 |
2011-09-21 |
味の素株式会社 |
アニリン誘導体
|
|
AU2005261487A1
(en)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Amide derivatives as inhibitors of histone deacetylase
|
|
JP4194540B2
(ja)
|
2004-07-27 |
2008-12-10 |
キヤノン株式会社 |
画像形成装置
|
|
US20110230479A1
(en)
|
2005-04-15 |
2011-09-22 |
Longo Frank M |
Neurotrophin mimetics and uses thereof
|
|
EP2586445A1
(en)
*
|
2005-04-15 |
2013-05-01 |
University Of North Carolina At Chapel Hill |
Methods of facilitating cell survival using neurotrophin mimetics
|
|
ES2569881T3
(es)
|
2005-06-08 |
2016-05-12 |
The University Of North Carolina At Chapel Hill |
Procedimientos para facilitar la supervivencia de células neuronales usando miméticos de neurotrofina BDNF peptídicos y no peptídicos
|
|
AU2006327181A1
(en)
|
2005-12-22 |
2007-06-28 |
Hydra Biosciences, Inc. |
TRPA1 inhibitors for treating pain
|
|
WO2008107365A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Medivir Ab |
New compounds
|
|
JP2012519703A
(ja)
*
|
2009-03-06 |
2012-08-30 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
ニューロトロフィン・ミメティック及びその使用
|
|
US10273219B2
(en)
|
2009-11-12 |
2019-04-30 |
Pharmatrophix, Inc. |
Crystalline forms of neurotrophin mimetic compounds and their salts
|
|
EP3470402B1
(en)
|
2009-11-12 |
2021-01-06 |
Pharmatrophix Inc. |
Crystalline forms of neurotrophin mimetic compounds and their salts
|
|
WO2011066544A2
(en)
|
2009-11-30 |
2011-06-03 |
Pharmatrophix, Inc. |
Deuterated compounds useful for treating neurodegenerative diseases
|
|
US20150259278A1
(en)
|
2012-09-27 |
2015-09-17 |
Pharmatrophix, Inc. |
Crystalline forms of neurotrophin mimetic compounds and their salts
|